ArticleBiomedicines2025

Dual Inhibition of HIF-1α and HIF-2α as a Promising Treatment for VHL-Associated Hemangioblastomas: A Pilot Study Using Patient-Derived Primary Cell Cultures.

Ana B Perona-Moratalla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.